Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Bath & Body Works Shares Hit New Low as Analyst Sentiment Sours

Felix Baarz by Felix Baarz
October 31, 2025
in Analysis, Consumer & Luxury
0
Bath & Body Works Stock
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Bath & Body Works shares have extended their decline, reaching a fresh 52-week low during Wednesday’s trading session. The stock closed at $24.82 after declining 4.9% for the day, signaling continued downward momentum that has investors concerned about when the slide might stabilize.

Financial Performance Metrics

While the company met expectations in its most recent quarterly report with earnings per share of $0.37 and revenue of $1.55 billion, deeper examination reveals underlying challenges. Revenue showed a year-over-year contraction of 0.8%, indicating potential headwinds for the business. The stock’s current trading position below key technical indicators—$27.35 for the 50-day moving average and $29.04 for the 200-day moving average—further underscores the negative trend. Even with a price-to-earnings ratio of 7.37 and market capitalization of $5.12 billion, investors remain cautious.

Analyst Downgrades and Price Target Cuts

Market analysts have responded to the deteriorating situation with significant adjustments to their assessments:

Should investors sell immediately? Or is it worth buying Bath & Body Works?

  • Jefferies Financial Group reduced its price target from $32.00 to $28.50 back in October
  • Wells Fargo & Company implemented a more substantial cut, lowering their target from $44.00 to $33.00
  • Wall Street Zen downgraded its rating from “Buy” to “Hold”

Analysts point to inconsistent product launches and mounting margin pressure as primary factors behind these revised outlooks.

Institutional Stance Amid Retail Exodus

As retail investors reduce their exposure, Victory Capital Management maintains its substantial position in the company. The investment firm holds 8.4 million shares, representing 4.08% of outstanding equity, and retains both voting and disposal rights. This institutional commitment raises questions about whether such support can potentially counterbalance the current negative momentum.

Market Context and Recent Performance

The broader consumer goods sector appears to be facing increasing headwinds, contributing to the challenging environment for Bath & Body Works. Recent trading patterns show the stock has declined in six of the last ten sessions, resulting in a cumulative loss of 8.0% over that period. With the stock establishing a new 52-week low at $24.84 during Wednesday’s session, market participants are watching closely for any signs of stabilization or reversal in the current trend.

Ad

Bath & Body Works Stock: Buy or Sell?! New Bath & Body Works Analysis from March 25 delivers the answer:

The latest Bath & Body Works figures speak for themselves: Urgent action needed for Bath & Body Works investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Bath & Body Works: Buy or sell? Read more here...

Tags: Bath & Body Works
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Ocugen Stock
Analysis

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
IBM Stock
Analysis

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Next Post
CSG Stock

Acquisition Deal Propels CSG Shares to Multi-Year High

Kinder Morgan Stock

Kinder Morgan Shares Hold Steady Amid Regulatory Review

Century Communities Stock

Century Communities Stock Surges on Exceptional Quarterly Performance

Recommended

Amazon Stock

Amazon Faces Regulatory Setback While Pushing AI and Retail Expansion

6 months ago
Energy Vault Holdings Stock

Energy Vault’s Strategic Pivot Gains Momentum with Major Texas Acquisition

5 months ago
COREWEAVE INC-CL A Stock

CoreWeave Shares Face Critical Earnings Test

5 months ago
Uranium Energy Stock

Uranium Energy Stock: A Market Paradox

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Trending

Energiekontor Stock
Energy & Oil

Energiekontor Stock Gains Momentum from Policy Shifts

by Rodolfo Hanigan
March 25, 2026
0

While Energiekontor's share price has faced significant headwinds this year, declining roughly 12% since January and over...

Bionxt Solutions Stock

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

March 25, 2026
Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Energiekontor Stock Gains Momentum from Policy Shifts
  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com